Perception of bronchoconstriction in obstructive pulmonary diseases (disease-specific dyspnoea)

dc.contributor.authorEkici, A.
dc.contributor.authorYilmaz, S.
dc.contributor.authorEkici, M.
dc.contributor.authorKalpaklioglu, F.
dc.contributor.authorKaradeniz, Y.
dc.contributor.authorArslan, M.
dc.contributor.authorKurtipek, E.
dc.date.accessioned2020-06-25T17:35:23Z
dc.date.available2020-06-25T17:35:23Z
dc.date.issued2003
dc.departmentKırıkkale Üniversitesi
dc.descriptionEkici, Arif B/0000-0001-6099-7066;
dc.description.abstractThe perception of dyspnoea differs between subjects with obstructive pulmonary diseases, partly because the underlying mechanisms for bronchoconstriction are different. We investigated the perception of bronchoconstriction in subjects with bronchiectasis, asthma and chronic bronchitis and possible contributing factors. Forty-seven non-smoking subjects with bronchiectasis, 50 subjects with asthma and 31 with chronic bronchitis were challenged with histamine. The Borg score was assessed before and after each challenge. The perception score corresponding to a fall in the forced expiratory volume in 1 s (FEV1)by 20% (PS20) was calculated. The mean values of DeltaBorg/DeltaFEV(1), (the Borg score change divided by the change in FEV1 as a percentage of the baseline FEV1) and PS20 of subjects with bronchiectasis and chronic bronchitis were significantly lower than in subjects with asthma after histamine challenge. The ratio of non-perceivers was higher in bronchiectasis (25.5%) and in chronic bronchitis (32.3%) than in asthma (4.0%). When all subjects were considered, DeltaBorg/DeltaFEV, values were significantly related to female sex(r(2)=11.5%, P=0.0001), but not to age, duration of the disease, PD20 or baseline FEV1%. The present study indicates that perception of histamine-induced bronchoconstriction is lower in patients with bronchiectasis and chronic bronchitis than in asthmatic patients, and that sex partially contributes to this difference.en_US
dc.identifier.citationclosedAccessen_US
dc.identifier.doi10.1042/CS20020364
dc.identifier.endpage185en_US
dc.identifier.issn0143-5221
dc.identifier.issn1470-8736
dc.identifier.issue2en_US
dc.identifier.pmid12667136
dc.identifier.scopus2-s2.0-0042090582
dc.identifier.scopusqualityQ1
dc.identifier.startpage181en_US
dc.identifier.urihttps://doi.org/10.1042/CS20020364
dc.identifier.urihttps://hdl.handle.net/20.500.12587/3106
dc.identifier.volume105en_US
dc.identifier.wosWOS:000184801800006
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherPortland Press Ltden_US
dc.relation.ispartofClinical Science
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectasthmaen_US
dc.subjectbronchiectasisen_US
dc.subjectchronic bronchitisen_US
dc.subjectdyspnoeaen_US
dc.subjectperceptionen_US
dc.titlePerception of bronchoconstriction in obstructive pulmonary diseases (disease-specific dyspnoea)en_US
dc.typeArticle

Dosyalar